Alice B Kornblith
Affiliation: Harvard University
- Cancer-related communication between female patients and male partners scale: A pilot studyAlice B Kornblith
Women s Cancers Program D 1210, Dana Farber Cancer Institute, Boston, MA 02115, USA
Psychooncology 15:780-94. 2006....
- Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B studyAlice B Kornblith
Women s Cancers Program, Dana Farber Cancer Institute, Rm D1210, 44 Binney Street, Boston, MA 02115, USA
J Clin Oncol 20:2441-52. 2002..The impact of azacytidine (Aza C) on the quality of life of 191 patients with myelodysplastic syndrome was assessed in a phase III Cancer and Leukemia Group B trial (9221)...
- Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trialsAlice B Kornblith
Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
Cancer 95:989-96. 2002....
- Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapyAlice B Kornblith
Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
Cancer 98:679-89. 2003....
- Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancerAlice B Kornblith
Breast Oncology Program Mayer 2, Dana Farber Cancer Institute, Boston, MA 02115, USA
Psychooncology 16:895-903. 2007..The study's objective was to test whether there were signfiicant differences in adjustment between younger and older breast and endometrial cancer survivors...
- Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group studyAlice B Kornblith
Division of Women s Cancers, Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
J Clin Oncol 27:5337-42. 2009..The study's objective was to compare the quality of life (QoL) of patients with endometrial cancer undergoing surgical staging via laparoscopy versus laparotomy...
- Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907Alice B Kornblith
Dana Farber Cancer Institute, Boston, MA, USA
J Clin Oncol 29:1022-8. 2011..The quality of life (QoL) substudy tested whether capecitabine treatment would be associated with a better QoL than standard chemotherapy...
- Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer: a cancer and leukemia group B studyAlice B Kornblith
Breast Oncology Program, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
Cancer 107:2706-14. 2006....
- Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907Rachel A Freedman
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
Breast Cancer Res Treat 139:607-16. 2013..In a healthy group of older women, chemotherapy was not associated with longitudinal changes in self-reported cognitive function...
- Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104Ann H Partridge
Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
J Clin Oncol 28:2418-22. 2010..Patient adherence is critical in evaluating the effectiveness of an oral therapy. We sought to measure adherence among women randomly assigned to capecitabine in a preplanned substudy of a multicenter clinical trial...
- Measuring psychosocial distress and parenting concerns among adults with cancer: the Parenting Concerns QuestionnaireAnna C Muriel
Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
Cancer 118:5671-8. 2012..Limited information about this area of psychosocial distress highlights the need for a measurement tool that can identify adult oncology patients with heightened parenting concerns who could benefit from additional intervention...
- Comparison of the quality of life of early and advanced stage ovarian cancer survivorsKristina L Mirabeau-Beale
Harvard Medical School, Boston, MA, USA
Gynecol Oncol 114:353-9. 2009..The objective of this study was to compare the long-term adjustment and QOL of early and advanced stage ovarian cancer survivors (OCS)...
- Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066Jeffrey Peppercorn
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
Cancer 104:1580-9. 2005..The patients were randomized to receive either high-dose chemotherapy with autologous stem cell support (HDC) or intermediate-dose chemotherapy (IDC) in the adjuvant setting...
- Psychosocial and sexual functioning of survivors of breast cancerAlice B Kornblith
Women s Cancers Program, Dana Farber Cancer Institute, Boston, MA 02115, USA
Semin Oncol 30:799-813. 2003..Those with long-term medical sequelae, such as lymphedema, have worse adjustment compared to those who do not. Future research directions are suggested...
- Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group BLewis R Silverman
Division of Medical Oncology, Mount Sinai School of Medicine and Memorial Sloan Kettering Cancer Center, Box 1129, One Gustave L Levy Place, New York, NY 10029, USA
J Clin Oncol 20:2429-40. 2002..Supportive care is standard therapy. We previously reported that azacitidine (Aza C) was active in patients with high-risk MDS...
- Barriers to clinical trial participation by older women with breast cancerM Margaret Kemeny
Cancer and Leukemia Group B and the University ofChicago Medical Center, IL, USA
J Clin Oncol 21:2268-75. 2003..This study tested whether older patients were offered trials significantly less often than younger patients and whether older patients who were offered trials were more likely to refuse participation than younger patients...
- Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001Gretchen G Kimmick
Duke University Medical Center, Suite 3800 Duke S, Box 3204, Durham, NC 27710, USA
J Clin Oncol 23:2201-7. 2005..To design and test a geriatric educational intervention to improve accrual of cancer patients age 65 years and older to cooperative group-sponsored treatment trials...
- Developing a cancer-specific geriatric assessment: a feasibility studyArti Hurria
Department of Medicine, Psychiatry and Behavioral Sciences, and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 104:1998-2005. 2005....
- Funding patient-reported outcomes in cancer clinical trialsCarol M Moinpour
Southwest Oncology Group Statistical Center Fred Hutchinson Cancer Research Center, Seattle, WA 98104 1024, USA
J Clin Oncol 25:5100-5. 2007....
- Pain predicts overall survival in men with metastatic castration-refractory prostate cancerSusan Halabi
Department of Biostatistics and Bioinformatics, Duke University, and Cancer and Leukemia Group B Statistical Center, Durham, NC, USA
J Clin Oncol 26:2544-9. 2008..The objective of this study was to determine whether men with CRPC who had higher pain interference scores at baseline had worse clinical outcomes compared with men who had lower pain scores...
- Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancerAndrea L Cheville
Department of Physical Medicine and Rehabilitation, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
J Clin Oncol 26:2621-9. 2008..We studied these issues by quantifying physical impairments in patients with metastatic breast cancer and by assessing how they are addressed...
- Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networksDeborah Watkins Bruner
Radiation Therapy Oncology Group, University of Pennsylvania, School of Nursing American College of Radiology Imaging Network, Philadelphia, PA 19104 6096, USA upenn edu
J Clin Oncol 25:5051-7. 2007..The objective of this report is to provide a historical overview of and the issues and challenges inherent in the incorporation of patient-reported outcomes (PROs) into multinational cancer clinical trials in the cancer cooperative groups...
- Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480Tim A Ahles
Norris Cotton Cancer Center, Department of Psychiatry, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA
Cancer 101:2202-8. 2004..The primary purpose of the current study was to evaluate whether there was evidence of palliative effects associated with suramin at any of the three doses administered in the original clinical trial...
- Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133Patricia A Ganz
University of California, Los Angeles, Los Angeles, CA, USA
J Clin Oncol 21:3512-9. 2003....
- The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancerAndrew J Roth
Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 97:2910-8. 2003..This scale consists of three subscales that measure general prostate cancer anxiety, anxiety related to prostate specific antigen (PSA) levels in particular, and fear of recurrence...
- Geriatric assessment for oncologists: rationale and future directionsArti Hurria
Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Crit Rev Oncol Hematol 59:211-7. 2006..Our eventual goal is to determine if this geriatric assessment measure can identify factors independent of age that predict cancer treatment morbidity and mortality and result in rationale interventions to optimize oncologic care...